ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LEON POVEDA M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,896Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 3593

$811K Total Retail Price of All Prescriptions

Rank: 216 out of 3593

900 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 900 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 900 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 25,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 1,446 1,372 1 4
AMLODIPINE BESYLATE 1,335 1,203 2 3
OMEPRAZOLE 1,254 1,136 3 5
LOVASTATIN 1,169 1,128 4 20
LISINOPRIL 882 795 5 2
SIMVASTATIN 868 782 6 1
ALENDRONATE SODIUM 698 652 7 22
LOSARTAN POTASSIUM 686 620 8 14
METFORMIN HCL 676 589 9 6
FUROSEMIDE 667 629 10 9
HYDROCHLOROTHIAZIDE 627 553 11 10
WARFARIN SODIUM 582 557 12 18
PRAVASTATIN SODIUM 536 487 13 13
METOPROLOL TARTRATE 527 459 14 8
ALPRAZOLAM 471 412 15 37
POTASSIUM CHLORIDE 452 410 16 24
TEMAZEPAM 445 394 17 56
GABAPENTIN 423 367 18 16
CARVEDILOL 380 354 19 23
ATENOLOL 371 354 20 11
TAMSULOSIN HCL 347 339 21 33
TRAMADOL HCL 322 278 22 17
CITALOPRAM HBR 311 273 23 25
ALLOPURINOL 282 256 24 35
DONEPEZIL HCL 279 279 25 31
GLIMEPIRIDE 271 254 26 44
ENALAPRIL MALEATE 262 217 27 38
ATORVASTATIN CALCIUM 261 218 28 15
BENAZEPRIL HCL 254 221 29 69
FENOFIBRATE 234 168 30 39
RANITIDINE HCL 211 182 31 27
METOPROLOL SUCCINATE 205 173 32 19
PANTOPRAZOLE SODIUM 203 186 33 45
CLOPIDOGREL 202 198 34 30
FINASTERIDE 202 201 34 79
HYDRALAZINE HCL 199 198 36 107
FLUTICASONE PROPIONATE 185 149 37 32
ISOSORBIDE MONONITRATE ER 180 180 38 61
PLAVIX 177 169 39 42
HYDROCODONE-ACETAMINOPHEN 165 156 S3 40 7
DOXAZOSIN MESYLATE 161 155 41 63
DILTIAZEM ER 161 161 41 194
LORAZEPAM 161 155 41 98
CLONIDINE HCL 161 149 41 41
LABETALOL HCL 157 152 45 220
OXYCODONE-ACETAMINOPHEN 152 113 S2 46 93
VENTOLIN HFA 147 123 47 80
CAPTOPRIL 147 147 47 213
CIPROFLOXACIN HCL 146 127 49 52
PREDNISONE 144 125 50 49
DIGOXIN 139 129 51 58
LANTUS 129 103 52 57
NIFEDIPINE ER 126 119 53 75
DOXYCYCLINE HYCLATE 116 99 54 141
TRIAMTERENE-HCTZ 114 113 55 66
GEMFIBROZIL 111 75 56 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 108 57 26
LOSARTAN-HYDROCHLOROTHIAZIDE 106 91 58 48
MELOXICAM 105 89 59 29
SPIRONOLACTONE 100 75 60 86
PAROXETINE HCL 99 83 61 62
FOSINOPRIL SODIUM 99 99 61 235
GLIPIZIDE 97 86 63 40
SERTRALINE HCL 96 80 64 28
FAMOTIDINE 96 84 64 70
LOVAZA 95 62 66 106
OXYCODONE HCL-ACETAMINOPHEN 93 69 S2 67 82
GENERLAC 93 93 67 271
OXYBUTYNIN CHLORIDE ER 92 74 69 175
SYNTHROID 91 72 70 51
ZOLPIDEM TARTRATE 90 83 71 12
OXYBUTYNIN CHLORIDE 86 86 72 104
ADVAIR DISKUS 85 79 73 47
AZITHROMYCIN 83 75 74 34
GLYBURIDE 83 79 R 74 55
RAMIPRIL 82 73 76 92
ENDOCET 82 62 S2 76 206
VIAGRA 80 55 78 84
NAMENDA 79 79 79 50
JANTOVEN 77 54 80 169
NEXIUM 74 44 81 36
CLOTRIMAZOLE-BETAMETHASONE 70 63 82 94
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 67 82 102
PROPRANOLOL HCL 69 54 84 181
EASY TOUCH 69 38 84 302
GLIPIZIDE ER 69 69 84 101
ESCITALOPRAM OXALATE 68 39 87 71
PRADAXA 63 63 88 325
BACLOFEN 61 37 89 109
LEVOXYL 61 61 89 111
METHYLPREDNISOLONE 59 54 91 103
AMIODARONE HCL 59 59 91 269
CRESTOR 58 53 93 21
MECLIZINE HCL 58 58 93 96
MUPIROCIN 57 47 95 132
CARBIDOPA-LEVODOPA 56 56 96 135
RISPERIDONE 56 51 96 83
CHOLESTYRAMINE 55 37 98 386
VOLTAREN 55 50 98 85
INSULIN SYRINGE 54 37 100 91
DIOVAN 54 46 100 46
PHENYTOIN SODIUM EXTENDED 53 42 102 165
SPIRIVA 52 52 103 87
DILTIAZEM 24HR ER 50 50 104 177
PRIMIDONE 50 50 104 282
AMLODIPINE BESYLATE-BENAZEPRIL 50 50 104 65
METOLAZONE 50 49 104 254
VERAPAMIL ER 50 47 104 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.